Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Documentation Practices During Method Development – V 2.0

Posted on By

Analytical Method Development: SOP for Documentation Practices During Method Development – V 2.0

Standard Operating Procedure for Documentation Practices in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/382/2025
Supersedes SOP/AMD/382/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2027

1. Purpose

The purpose of this SOP is to establish a standardized approach for documentation during the development of analytical methods to ensure Good Documentation Practices (GDP), traceability, reproducibility, and compliance with cGMP and regulatory expectations.

2. Scope

This SOP applies to

all personnel involved in method development activities within the Analytical Method Development (AMD) department, including wet lab experimentation, protocol writing, data analysis, and reporting.

3. Responsibilities

  • Analytical Scientist: Responsible for generating and maintaining experimental records accurately and in real time.
  • QA Reviewer: Verifies documentation for compliance, completeness, and data integrity.
  • Documentation Coordinator: Ensures indexing, archival, and retrieval of development records and electronic data.
  • Department Head: Oversees overall compliance and addresses documentation-related deviations or observations.

4. Accountability

The Head of the Analytical Method Development department is accountable for enforcing proper documentation practices and ensuring training and adherence by all team members.

See also  Analytical Method Development: SOP for Isolation and Characterization of Unknown Impurities - V 2.0

5. Procedure

5.1 General Principles of Good Documentation Practices (GDP)

  • All entries must be legible, permanent, and accurate.
  • Write entries in ink (blue or black); no pencil entries are permitted.
  • Use single-line cross-outs for corrections, initial, date, and provide justification if required.
  • All data must be recorded in real-time, not on scraps or post-experiment notes.
  • Never leave blank spaces; use “NA” or “Not Applicable” with reason.

5.2 Document Types and Their Handling

  1. Method Development Protocols: Outline experimental objectives, parameters, and evaluation criteria.
  2. Raw Data Sheets: Printouts, chromatograms, analytical weights, pH, temperature logs must be numbered, signed, and dated.
  3. Analyst Worksheets: Used to log each step and observation. Maintain pagination and cross-reference attachments.
  4. Laboratory Notebooks: Every page should be signed by analyst and reviewer; pagination must be pre-printed or pre-numbered.
  5. Electronic Data: Ensure audit trails are active. File names must follow naming conventions (e.g., AMD-MDP-001-HPLC-Inj001).

5.3 Recording Experimental Observations

  1. Include:
    • Date and time of experiment
    • Analytical method number/version
    • Instrument and column ID numbers
    • Environmental conditions (for sensitive assays)
    • Batch numbers of reference standards or chemicals used
  2. Observations should be descriptive and quantitative wherever possible (e.g., “solution turned turbid after 3 minutes”).
See also  Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer - V 2.0

5.4 Documentation of Changes and Deviations

  1. All changes to method parameters (e.g., flow rate, mobile phase composition) must be:
    • Documented in the experimental worksheet
    • Justified with scientific rationale
    • Authorized by a senior analyst or supervisor
  2. Significant deviations must be recorded in the deviation log (Annexure-1) and reported to QA within 24 hours.

5.5 Review and Verification

  1. QA or peer reviewers must:
    • Verify completeness of records
    • Ensure calculations are accurate and traceable
    • Check consistency with protocol and reported results
  2. Use Annexure-2 checklist for systematic review of documentation practices.

5.6 Archival and Retrieval

  1. All completed protocols, notebooks, and electronic data files must be indexed and archived by the Documentation Officer.
  2. Maintain both physical and digital records in the central AMD repository with access logs and retrieval SOP compliance.

6. Abbreviations

  • GDP: Good Documentation Practices
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure
  • AMD: Analytical Method Development
See also  Analytical Method Development: Reagent Qualification for Method Development - V 2.0

7. Documents

  1. Annexure-1: Method Development Deviation Log
  2. Annexure-2: Documentation Compliance Checklist
  3. Analytical Method Development Protocol Template

8. References

  • WHO Annex 3 – Good Documentation Practices
  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 11 – Electronic Records and Signatures
  • EU GMP Annex 11 – Computerised Systems

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Megha Sharma Santosh Rathi Dr. Harshita Goyal
Designation Analytical Scientist QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Method Development Deviation Log

Deviation ID Description Date Analyst Action Taken
DEV-382-01 Omitted solvent pH adjustment 29/05/2025 M. Sharma Protocol updated

Annexure-2: Documentation Compliance Checklist

  • Are all worksheets paginated and signed?
  • Is all raw data attached and cross-referenced?
  • Are corrections compliant with GDP?
  • Are deviations documented and justified?

Revision History

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Included new annexures and digital documentation handling Periodic SOP Review Dr. Harshita Goyal
20/05/2022 1.0 Initial SOP release New Document QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Determination of System Suitability Criteria – V 2.0
Next Post: Analytical Method Development: SOP for Conducting Forced Degradation Studies – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version